Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Adipose-derived mesenchymal stromal cells and their acellular derivatives in cutaneous wound healing and pathological scarring: a narrative review.

Akbari N., Heidari B., Totonchi M.

Narrative Review on Chronic Wound, Scar, published in Cell Tissue Bank (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cell Tissue Bank (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
42435237
DOI
10.1007/s10561-026-10238-y

Abstract (original English)

Cutaneous wound healing is a tightly regulated biological process that restores tissue integrity following injury. Dysregulation of inflammation, fibroblast activity, extracellular matrix remodeling, and angiogenesis can result in delayed healing or pathological scarring, including hypertrophic scars and keloids. Conventional scar-management strategies, such as intralesional corticosteroids, surgical excision, radiotherapy, laser therapy, cryotherapy, silicone-based products, and pressure therapy, remain limited by variable efficacy, recurrence, adverse effects, and inconsistent long-term outcomes. Consequently, regenerative approaches based on adipose-derived mesenchymal stromal cells (ASCs) and ASC-derived acellular products have attracted increasing attention This narrative review synthesizes current evidence regarding ASC-based therapies and ASC-derived acellular products, including conditioned medium, soluble factors, ASC-derived nanovesicle therapy (extracellular vesicle preparations), and apoptotic extracellular vesicles, in cutaneous wound healing and pathological scar modulation. Particular emphasis is placed on scar-relevant mechanisms, including regulation of inflammation and macrophage polarization, modulation of fibroblast and myofibroblast activity, collagen remodeling, angiogenesis, re-epithelialization, transforming growth factor-β/Smad signaling, α-smooth muscl

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansWound HealingMesenchymal Stem CellsAdipose TissueAnimalsCicatrixSkinMesenchymal Stem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research